Dusopharm, pills 50mg, 60pcs

Composition

Film-coated tablets orange color, round, biconvex.

1 tab. naphthidrofuryl oxalate 50 mg

Excipients:

lactose monohydrate,

microcrystalline cellulose,

wheat starch,

copovidone,

colloidal silicon dioxide,

magnesium stearate,

talc.

Shell composition:

titanium dioxide, talc, magnesium stearate, macrogol 6000, methacrylic acid and ethyl acrylate copolymer, dye sunset yellow (E 110).

Pharmacological action

 A drug that improves brain and peripheral blood circulation

Indications

recovery period after cerebral circulatory disorders; peripheral circulatory disorders (intermittent claudication, Raynaud’s disease, trophic ulcers).

Contraindications

individual hypersensitivity to the drug;myocardial infarction (acute phase);hypotension;hemorrhagic stroke (acute phase);epilepsy, increased convulsive readiness;chronic heart failure II–III stage (III–IV NYHA functional classification of heart failure new York heart Association);tachyarrhythmia;age to 18 years (efficacy and safety not established). With caution: angle-closure glaucoma;prostatic hyperplasia.

Side effects

When taken orally in doses from 300 to 600 mg, Dusofarm is generally well tolerated. Possible side effects: nausea, vomiting, epigastric pain, intestinal colic, diarrhea, decreased appetite, headache, dizziness, sleep disturbance, reversible increase in liver enzyme activity, ulcers of the gastric mucosa, allergic reactions.

Interaction

Increases the antihypertensive effect of antihypertensive drugs.

In this regard, more frequent monitoring of blood pressure is recommended — at the beginning of combined treatment with Dusopharm and antihypertensive agents.

How to take, course of use and dosage

Inside, whole, without chewing, with a sufficient amount of liquid, (it is recommended to drink water). For disorders of cerebral circulation: in a daily dose of 300 mg (2 tablets 3 times a day). In case of peripheral circulatory disorders: in a daily dose of 500-600 mg (in 3 divided doses). Duzopharm is recommended for long-term oral therapy (up to 6 months). No dose adjustment is required in patients with renal/hepatic insufficiency.

Overdose

Symptoms: increased severity of side effects, ventricular arrhythmia, anxiety, decreased blood pressure, bradycardia. Treatment: gastric lavage, use of activated charcoal and laxatives, symptomatic treatment. There is no specific antidote.

Special instructions

Duzopharm does not adversely affect psychomotor reactions and the ability to drive a car. At the beginning of treatment, it is recommended to monitor the individual tolerability of the drug and monitor the possible hypotensive effect in the respective patients. The drug contains lactose monohydrate, so it is not recommended to use it for people suffering from lactase deficiency, galactosemia or glucose-galactose malabsorption syndrome. Patients with celiac disease (gluten enteropathy) should consider that the tablet contains wheat starch.

Active ingredient

Naftidrofuryl

Conditions of release from pharmacies

By prescription

Dosage form

Tablets

Description

For adults

Indications

Raynaud’s disease, Trophic Ulcers, Cerebrovascular accident